OA10593A - Benzopyrans and their use as therapeutic agents - Google Patents

Benzopyrans and their use as therapeutic agents Download PDF

Info

Publication number
OA10593A
OA10593A OA60933A OA60933A OA10593A OA 10593 A OA10593 A OA 10593A OA 60933 A OA60933 A OA 60933A OA 60933 A OA60933 A OA 60933A OA 10593 A OA10593 A OA 10593A
Authority
OA
OAPI
Prior art keywords
benzopyran
disease
dihydro
acetyl
pharmaceutically acceptable
Prior art date
Application number
OA60933A
Other languages
English (en)
Inventor
Wai Ngor Chan
Helen Kate Ann Morgan
Mervyn Thompson
John Morris Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411632A external-priority patent/GB9411632D0/en
Priority claimed from GB9411798A external-priority patent/GB9411798D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA10593A publication Critical patent/OA10593A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
OA60933A 1994-06-10 1996-12-10 Benzopyrans and their use as therapeutic agents OA10593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411632A GB9411632D0 (en) 1994-06-10 1994-06-10 Novel treatment
GB9411798A GB9411798D0 (en) 1994-06-13 1994-06-13 Novel treatment

Publications (1)

Publication Number Publication Date
OA10593A true OA10593A (en) 2002-07-10

Family

ID=26305044

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60933A OA10593A (en) 1994-06-10 1996-12-10 Benzopyrans and their use as therapeutic agents

Country Status (29)

Country Link
US (1) US5760074A (no)
EP (2) EP1114821B1 (no)
JP (2) JP3575767B2 (no)
KR (1) KR100397721B1 (no)
CN (2) CN1174975C (no)
AP (1) AP714A (no)
AT (2) ATE250052T1 (no)
AU (1) AU701060B2 (no)
BG (1) BG63339B1 (no)
BR (1) BR9507980A (no)
CA (1) CA2192480C (no)
CY (1) CY2508B1 (no)
CZ (1) CZ286081B6 (no)
DE (2) DE69524871T2 (no)
DK (2) DK1114821T3 (no)
ES (2) ES2207590T3 (no)
FI (1) FI120686B (no)
HK (2) HK1001286A1 (no)
HU (1) HUT76136A (no)
NO (1) NO315651B1 (no)
NZ (1) NZ287872A (no)
OA (1) OA10593A (no)
PL (1) PL188134B1 (no)
PT (2) PT1114821E (no)
RO (1) RO113463B1 (no)
SG (1) SG67930A1 (no)
SI (2) SI1114821T1 (no)
SK (1) SK281456B6 (no)
WO (1) WO1995034545A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021780A1 (en) * 1992-12-11 2001-09-13 Smithkline Beecham P.L.C. Pharmaceutical composition containing bicyclic type compounds
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
US6492415B2 (en) * 1996-09-18 2002-12-10 Smithkline Beecham P.L.C. Use of benzopyranols to treat neurological disorders
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
GB0028697D0 (en) * 2000-11-23 2001-01-10 S P A Novel process
CA2602267A1 (en) * 2005-04-04 2006-10-12 Takeda Pharmaceutical Company Limited Use of ramelteon to treat and prevent depression and anxiety disorders
CA2726874A1 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
WO2011067607A1 (en) 2009-12-03 2011-06-09 Minster Research Ltd Treatment of infectious diseases
RU2012124837A (ru) 2009-12-03 2014-01-10 Проксимэджен ЛТД Лечение аллодинии и гипералгезии
EP2870148A1 (en) 2012-07-03 2015-05-13 Proximagen Limited Pro-drug compounds
GB201304814D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds
GB201322932D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Pro-drug compounds
GB201322934D0 (en) 2013-12-23 2014-02-12 Proximagen Ltd Prodrug compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126311B1 (en) * 1983-05-18 1989-09-13 Beecham Group Plc Benzopyran derivatives.
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
NZ258610A (en) * 1992-12-11 1997-05-26 Smithkline Beecham Plc Various 4-acylamino-2h-benzo[b]pyran-3-ol derivatives;use in preparation of medicaments
DK0673374T3 (da) * 1992-12-11 2000-07-31 Smithkline Beecham Corp Farmaceutisk præparat, der indeholder bicykliske forbindelsestyper
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
SK158796A3 (en) 1997-07-09
DK1114821T3 (da) 2004-02-02
ES2207590T3 (es) 2004-06-01
ATE211469T1 (de) 2002-01-15
CZ361796A3 (en) 1997-08-13
JPH10501251A (ja) 1998-02-03
HK1039115A1 (en) 2002-04-12
PL317579A1 (en) 1997-04-14
AP714A (en) 1998-12-23
EP0764157A1 (en) 1997-03-26
AP9600889A0 (en) 1997-01-31
JP2003238554A (ja) 2003-08-27
SI0764157T1 (en) 2002-06-30
ATE250052T1 (de) 2003-10-15
NO315651B1 (no) 2003-10-06
FI120686B (fi) 2010-01-29
CN1234702C (zh) 2006-01-04
DE69531801T2 (de) 2004-07-01
DK0764157T3 (da) 2002-04-22
DE69531801D1 (de) 2003-10-23
RO113463B1 (ro) 1998-07-30
HK1039115B (zh) 2004-08-13
PL188134B1 (pl) 2004-12-31
FI964936A0 (fi) 1996-12-10
DE69524871D1 (de) 2002-02-07
EP0764157B1 (en) 2002-01-02
DE69524871T2 (de) 2002-08-22
CY2508B1 (en) 2005-12-23
FI964936A (fi) 1997-02-06
US5760074A (en) 1998-06-02
AU701060B2 (en) 1999-01-21
CA2192480A1 (en) 1995-12-21
HK1001286A1 (en) 1998-06-12
EP1114821B1 (en) 2003-09-17
CN1174975C (zh) 2004-11-10
PT1114821E (pt) 2004-02-27
JP3575767B2 (ja) 2004-10-13
SG67930A1 (en) 1999-10-19
CN1154698A (zh) 1997-07-16
KR100397721B1 (ko) 2004-04-28
AU2672795A (en) 1996-01-05
ES2170798T3 (es) 2002-08-16
WO1995034545A1 (en) 1995-12-21
BG63339B1 (bg) 2001-10-31
NO965260D0 (no) 1996-12-09
SI1114821T1 (en) 2004-02-29
BG101040A (en) 1997-08-29
CA2192480C (en) 2007-07-24
NZ287872A (en) 1998-05-27
PT764157E (pt) 2002-06-28
SK281456B6 (sk) 2001-03-12
EP1114821A1 (en) 2001-07-11
CZ286081B6 (cs) 2000-01-12
NO965260L (no) 1997-02-06
HU9603415D0 (en) 1997-02-28
CN1336369A (zh) 2002-02-20
HUT76136A (en) 1997-06-30
BR9507980A (pt) 1997-08-12

Similar Documents

Publication Publication Date Title
OA10593A (en) Benzopyrans and their use as therapeutic agents
EP0673374B1 (en) Pharmaceutical composition containing bicyclic type compounds
AU679475B2 (en) Bicyclic compounds with pharmaceutical activity
WO1994013292A1 (en) Potassium channel activators for use in therapy
EP0764158B1 (en) Benzopyrans and their use as therapeutic agents
WO1995034547A1 (en) C-4 amide substituted compounds and their use as therapeutic agents
AU739678B2 (en) Benzopyrans and their use as therapeutic agents
CA2151507C (en) Pharmaceutical composition containing bicyclic type compounds
US20020123630A1 (en) Pharmaceutical composition containing bicyclic type compounds
WO1994013297A1 (en) Potassium channel activators and use thereof in therapy
UA62909C2 (en) Benzopyrans, benzopyran-containing pharmaceutical composition, method for treatment and/or prevention of diseases